Chemical formula of Itraconazole
0

Itraconazole - Sporanox Analysis

€149.00
Tax included
ITRACONAZOLE

Laboratory analysis of drugs to certify the presence of itraconazole and measure its concentration.

The level of uncertainty of the itraconazole content analysis depends on the declination selected (Standard <20%, Precise <10% or Regulatory <5%).

Follow the instructions to send your drug to our laboratory for analysis.

Results within 15 working days of receipt of sample.

Analysis: Standard

Itraconazole is a triazole antifungal agent used primarily for the treatment of systemic and cutaneous fungal infections, including aspergillosis, candidiasis, onychomycosis and histoplasmosis.

Itraconazole is the active ingredient in Sporanox, marketed by Janssen Pharmaceuticals, as well as several other generics.

Consuming medicines ordered from dubious or illegal sites can be hazardous to your health. It is essential to check that the online pharmacy is reputable and fully licensed.

If you have any doubts about the origin of the drug, you should carry out an analysis to certify the presence of the active ingredient and check that its dosage in the drug complies with the indicated content.

Analysis

Itraconazole is analyzed by liquid chromatography coupled with UV-Visible spectrophotometric detection (HPLC-UV Visible).

Chemical name

  • Nom chimique : (2R,4S)-rel-1-(butan-2-yl)-4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-1,2,4-triazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]pipérazin-1-yl]phényl]-4,5-dihydro-1H-1,2,4-triazol-5-one
  • Gross formula: C35H38Cl2N8O4
  • CAS number: 84625-61-6

Therapeutic class

Itraconazole belongs to the triazole class of antifungals, used mainly for :

  • Treatment of invasive fungal infections, including aspergillosis, histoplasmosis and blastomycosis.
  • Treatment of skin infections and nail fungus (onychomycosis).
  • Treatment of recurrent oral and vaginal candidiasis.

Description of therapeutic effects

Itraconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to their destruction.

  • Broad antifungal spectrum: active against Aspergillus, Candida, Histoplasma and other pathogenic fungi.
  • Improved bioavailability in oral solution form compared to capsules.
  • Used for prevention in immunocompromised patients to avoid invasive fungal infections.

Trade names

  • Sporanox
  • Itraconazole Teva
  • Itraconazole Mylan
  • Itraconazole Sandoz
  • Other generics available

Main manufacturers

  • Janssen Pharmaceuticals
  • Teva Pharmaceuticals
  • Mylan
  • Sandoz
  • Pfizer

Precautions and side effects

Precautions for use

  • Contraindicated in cases of hypersensitivity to azole antifungals.
  • Risk of significant drug interactions with drugs metabolized by CYP3A4 (statins, anticoagulants, immunosuppressants).
  • Avoid use in cases of hepatic or cardiac insufficiency (may aggravate congestive heart failure).
  • Absorption optimized if taken with an acidic meal (avoid antacids).
  • Not recommended during pregnancy or breast-feeding, unless absolutely necessary.

Possible side effects

  • Common: nausea, vomiting, abdominal pain, diarrhea.
  • Occasional: rash, headache, increased liver enzymes.
  • Rare but serious: hepatotoxicity, congestive heart failure, heart rhythm disorders (QT prolongation), severe allergic reactions.

⚠️ Drug interactions: Itraconazole may increase the plasma concentration of certain drugs, necessitating dose adjustment (e.g. ciclosporin, digoxin, warfarin).

ITRACONAZOLE

Specific References

Your drug is analyzed by our expert pharmaceutical analysis laboratory.

The drug to be analyzed must be sent in at least 3 copies in its original packaging (box or vial + blister pack) in order to have all the information.

The drug to be analyzed must be sufficiently protected to avoid any deterioration or damage during transport.

The drug to be analyzed must be accompanied by the completed analysis form.

Documents to download:

The use of counterfeit or illegal medicines (without patent authorisation) presents a proven risk to patients' health:

  • Absence of the active ingredient
  • Under-dosage of the active ingredient
  • Over-dosage of the active ingredient
  • Toxic synthetic or degradation impurities
  • Presence of another active ingredient
  • Toxic excipients
  • Presence of toxic residual solvents
  • ...

The trade in counterfeit medicines is flourishing and growing exponentially with online trading. The authorities believe that more than half of all medicines sold over the Internet are counterfeit or illegal.

Comments (0)

Itraconazole - Sporanox...

€149.00